Q1 2025 13F Holders as of 31 Mar 2025
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
152M
-
Number of holders
-
570
-
Total 13F shares, excl. options
-
160M
-
Shares change
-
+3.91M
-
Total reported value, excl. options
-
$9.41B
-
Value change
-
+$179M
-
Put/Call ratio
-
0.16
-
Number of buys
-
273
-
Number of sells
-
-271
-
Price
-
$58.63
Significant Holders of BIO-TECHNE Corp - COMMON STOCK (TECH) as of Q1 2025
646 filings reported holding TECH - BIO-TECHNE Corp - COMMON STOCK as of Q1 2025.
BIO-TECHNE Corp - COMMON STOCK (TECH) has 570 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 160M shares
.
Largest 10 shareholders include VANGUARD GROUP INC (18.5M shares), BlackRock, Inc. (13.7M shares), PRICE T ROWE ASSOCIATES INC /MD/ (11.4M shares), STATE STREET CORP (6.53M shares), MORGAN STANLEY (5.72M shares), Select Equity Group, L.P. (5.37M shares), Invesco Ltd. (4.19M shares), GEODE CAPITAL MANAGEMENT, LLC (4.09M shares), AMERIPRISE FINANCIAL INC (3.59M shares), and BAMCO INC /NY/ (3.28M shares).
This table shows the top 570 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.